Mithun V Shah MD PhD

Oncology•Rochester, MN

Hematologic Oncology

Hematologist, Mayo Clinic Comprehensive Cancer Center in Rochester, Minnesota

Join to View Full Profile

200 1st Street SWRochester, MN 55905

Summary

Dr. Shah is a Hematologist in Rochester, MN. He completed his Hematology/Oncology Fellowship from Mayo Clinic, Rochester and Stem Cell Transplant/CART Fellowship from MD Anderson.

His expertise includes management of myeloid neoplasms and cellular therapies. He has published in reputed journals such as PNAS, Lancet Oncology, JCO, JCI, JAMA Oncology, Blood, and Leukemia.

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2013 - 2017
Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 2010 - 2013
B. J. Medical College AhmedabadClass of 2002

Certifications & Licensure

MN State Medical License 2013 - 2026
PA State Medical License 2010 - 2013
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Clinical characteristics and prognostic significance of co-mutated SETBP1/GATA2 myeloid neoplasms.
Yazan Jabban, Rong He, Kurt Bessonen, Patricia Greipp, Dragan Jevremovic
Leukemia Research. 2025-08-01
2 citations
Factors associated with survival after allogeneic transplantation for myeloid neoplasms harboring TP53 mutations.
Anmol Baranwal, Kimberly J Langer, Vedavyas Gannamani, Danielle Rud, Alia Cibich
Blood Advances. 2025-07-22
Characteristics of patients with newly diagnosed acute myeloid leukemia not receiving treatment.
Oudai Alkabbani, Yazan Jabban, Rong He, David Viswanatha, Kurt Bessonen
Haematologica. 2025-07-17

Journal Articles

Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction Drugs
Krina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature

Abstracts/Posters

Acute Myeloid Leukemia with High Risk Features: Routine Central Nervous System Evaluation May be Beneficial
Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Clinical Features and Outcomes of Unifocal Adult Langerhans Cell Histiocytosis
Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Characteristics and Outcomes of Therapy Related Myeloid Neoplasms in Patients with Multiple Myeloma Following Autologous Stem Cell Transplantation
Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Molecular Alterations in Adult Histiocytic Neoplasms
Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Survival Outcomes Following Allogeneic Stem Cell Transplantation for Inherited Bone Marrow Failure and Myeloid Germline Predisposition Syndromes
Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Flurabine Improves Transplant Outcomes in Older MDS Patients
Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Peak Lymphocyte Count after CAR T Infusion Is a Clinically Accessible Test That Correlates with Clinical Response in Axicabtagene Ciloleucel Therapy for Lymphoma
Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Single-Agent Cladribine As an Effective Therapy for Adults with Langerhans Cell Histiocytosis
Mithun Vinod Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Join now to see all

Lectures

Tumor Mutational Burden and Other Immunotherapy Markers in Histiocytic Neoplasms Using Next Generation Sequencing
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018